Press Releases - Page 4 of 5 - F-Star Therapeutics Inc.

Feb 20, 2020

F-star Therapeutics to Participate in the BTIG Targeted Therapeutics Conference »

Jan 30, 2020

F-star Therapeutics Announces FDA Acceptance of IND Application for FS120 »

Jan 9, 2020

F-star Therapeutics Appoints Dr. Edward Benz and Mr. Geoff Race to Board of Directors »

Nov 8, 2019

F-star Presents New Data on OX40/CD137 Tetravalent Bispecific Antibody at the SITC 2019 Annual Meeting »

Jun 18, 2019

F-star appoints Darlene Deptula-Hicks as CFO »

Jun 10, 2019

F-star appoints Dr Louis Kayitalire as CMO »

May 30, 2019

F-star updates on FS118 clinical trial and announces presentation at ASCO 2019 »

May 14, 2019

F-star expedites its transition to a wholly-owned portfolio strategy »

Mar 25, 2019

F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting »

Nov 29, 2018

F-star Wins “Best Partnership Alliance” Award at the 14th Annual Scrip Awards Ceremony »

Nov 1, 2018

F-star to Disclose Targets and Preclinical Data on New Agonist Bispecific Antibody Programmes »

Oct 15, 2018

F-star Appoints Dr Eliot Forster as Chief Executive Officer »

Sep 10, 2018

F-star Appoints Nessan Bermingham as Chairman of its Board of Directors »

Jul 24, 2018

F-star Announces the Achievement of a Clinical Milestone in its Immuno-Oncology Collaboration with Merck »

May 30, 2018

F-star Announces Early Exercise by Denali Therapeutics of its Option to Acquire F-star Gamma »

May 21, 2018

F-star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody »

Apr 9, 2018

F-star to Present New Preclinical Data on FS118, a First-in-Class Immuno-Oncology Bispecific Antibody, at the AACR 2018 Annual Meeting »

Jan 9, 2018

F-star Provides an Update on its Collaboration with Denali Therapeutics »

Sep 22, 2017

F-star Recognised as a Finalist in Two Categories of the Scrip Awards 2017 »

Sep 15, 2017

F-star Wins “UK Life Sciences Deal of the Year” and “UK Life Sciences CEO of the Year” at the Biotech and Money 2017 Awards »

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others